Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

Affordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...

A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...

A family who know how devastating a cystic fibrosis diagnosis can be recently tackled an assault course in support of poorly ...

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...